JP7111389B2 - 緩下用錠剤 - Google Patents

緩下用錠剤 Download PDF

Info

Publication number
JP7111389B2
JP7111389B2 JP2020556190A JP2020556190A JP7111389B2 JP 7111389 B2 JP7111389 B2 JP 7111389B2 JP 2020556190 A JP2020556190 A JP 2020556190A JP 2020556190 A JP2020556190 A JP 2020556190A JP 7111389 B2 JP7111389 B2 JP 7111389B2
Authority
JP
Japan
Prior art keywords
tablet
magnesium oxide
volume
disintegrant
suspended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020556190A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020101016A1 (ja
Inventor
篤之 服部
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Chemical Industry Co Ltd
Original Assignee
Kyowa Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Chemical Industry Co Ltd filed Critical Kyowa Chemical Industry Co Ltd
Publication of JPWO2020101016A1 publication Critical patent/JPWO2020101016A1/ja
Priority to JP2022087199A priority Critical patent/JP7360503B2/ja
Application granted granted Critical
Publication of JP7111389B2 publication Critical patent/JP7111389B2/ja
Priority to JP2023170375A priority patent/JP7657275B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2020556190A 2018-11-16 2019-11-15 緩下用錠剤 Active JP7111389B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022087199A JP7360503B2 (ja) 2018-11-16 2022-05-27 緩下用錠剤
JP2023170375A JP7657275B2 (ja) 2018-11-16 2023-09-29 緩下用錠剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018215180 2018-11-16
JP2018215180 2018-11-16
PCT/JP2019/044876 WO2020101016A1 (ja) 2018-11-16 2019-11-15 緩下用錠剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022087199A Division JP7360503B2 (ja) 2018-11-16 2022-05-27 緩下用錠剤

Publications (2)

Publication Number Publication Date
JPWO2020101016A1 JPWO2020101016A1 (ja) 2021-09-02
JP7111389B2 true JP7111389B2 (ja) 2022-08-02

Family

ID=70731929

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020556190A Active JP7111389B2 (ja) 2018-11-16 2019-11-15 緩下用錠剤
JP2022087199A Active JP7360503B2 (ja) 2018-11-16 2022-05-27 緩下用錠剤
JP2023170375A Active JP7657275B2 (ja) 2018-11-16 2023-09-29 緩下用錠剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022087199A Active JP7360503B2 (ja) 2018-11-16 2022-05-27 緩下用錠剤
JP2023170375A Active JP7657275B2 (ja) 2018-11-16 2023-09-29 緩下用錠剤

Country Status (7)

Country Link
US (1) US12053549B2 (https=)
EP (1) EP3881897B1 (https=)
JP (3) JP7111389B2 (https=)
KR (1) KR102682646B1 (https=)
CN (1) CN113015555B (https=)
TW (1) TWI724629B (https=)
WO (1) WO2020101016A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7233516B2 (ja) * 2021-07-30 2023-03-06 セトラスホールディングス株式会社 酸化マグネシウムを含有する小児慢性機能性便秘症治療用医薬組成物
JP7340572B2 (ja) * 2021-08-20 2023-09-07 セトラスホールディングス株式会社 酸化マグネシウム錠剤
CN115487160A (zh) * 2022-09-27 2022-12-20 威海百合生物技术股份有限公司 一种氧化镁片及其制备方法
CN120036483B (zh) * 2025-01-06 2026-03-27 仙乐健康科技股份有限公司 一种微胶囊、片剂及其制备方法和应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006022060A (ja) 2004-07-09 2006-01-26 Kyowa Chem Ind Co Ltd 制酸・緩下用水分散液およびそのための錠剤
JP2009522315A (ja) 2006-01-05 2009-06-11 ライフサイクル ファーマ エー／エス 崩壊性の充填可能な錠剤
JP2010526811A (ja) 2007-05-08 2010-08-05 ハーキュリーズ・インコーポレーテッド 堅牢な迅速崩壊錠剤の処方
WO2011030659A1 (ja) 2009-09-08 2011-03-17 協和化学工業株式会社 制酸・緩下用錠剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8710965D0 (en) * 1987-05-08 1987-06-10 Smith Kline French Lab Pharmaceutical compositions
JP4015485B2 (ja) 2001-08-27 2007-11-28 協和化学工業株式会社 制酸・緩下用錠剤
KR20080099353A (ko) * 2001-08-27 2008-11-12 교와 가가꾸고교 가부시키가이샤 제산 ·완하용 정제
CA2687063C (en) 2007-05-11 2017-04-04 Aloebiotics Research Labs, Inc. Aloe preparation for skin enhancement
JP2010265208A (ja) 2009-05-14 2010-11-25 Kyowa Chem Ind Co Ltd 膵臓機能強化乃至活性化用複合酸化マグネシウム粒子
JP2014224080A (ja) * 2013-05-17 2014-12-04 協和化学工業株式会社 大腸の検査または手術のための処置剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006022060A (ja) 2004-07-09 2006-01-26 Kyowa Chem Ind Co Ltd 制酸・緩下用水分散液およびそのための錠剤
JP2009522315A (ja) 2006-01-05 2009-06-11 ライフサイクル ファーマ エー／エス 崩壊性の充填可能な錠剤
JP2010526811A (ja) 2007-05-08 2010-08-05 ハーキュリーズ・インコーポレーテッド 堅牢な迅速崩壊錠剤の処方
WO2011030659A1 (ja) 2009-09-08 2011-03-17 協和化学工業株式会社 制酸・緩下用錠剤

Also Published As

Publication number Publication date
US12053549B2 (en) 2024-08-06
CN113015555A (zh) 2021-06-22
TWI724629B (zh) 2021-04-11
EP3881897B1 (en) 2026-02-18
CN113015555B (zh) 2023-05-30
US20210401754A1 (en) 2021-12-30
JPWO2020101016A1 (ja) 2021-09-02
WO2020101016A1 (ja) 2020-05-22
EP3881897A4 (en) 2022-08-10
JP7360503B2 (ja) 2023-10-12
EP3881897A1 (en) 2021-09-22
KR102682646B1 (ko) 2024-07-09
TW202031249A (zh) 2020-09-01
KR20210076066A (ko) 2021-06-23
JP2023165999A (ja) 2023-11-17
JP2022105754A (ja) 2022-07-14
JP7657275B2 (ja) 2025-04-04

Similar Documents

Publication Publication Date Title
JP7657275B2 (ja) 緩下用錠剤
KR101506043B1 (ko) 저치환도 히드록시프로필셀룰로오스를 함유하는 의약 조성물
KR102631488B1 (ko) 디아민 유도체를 함유하는 구강내 붕괴정
KR20100126266A (ko) 약학 조성물
EP3113770A1 (en) Orally disintegrating tablet of nabilone comprising mannitol-based granules
JP5318400B2 (ja) レボフロキサシン含有錠剤
KR20120098878A (ko) 용출 안정성 제제
US8741344B1 (en) Dispersible tablet
Amrutkar et al. Design and evaluation of taste masked chewable dispersible tablet of lamotrigine by melt granulation
JP4853818B2 (ja) イブプロフェン及び塩酸アンブロキソール含有固形製剤
KR20160030093A (ko) 구강 내 붕괴정
KR20140076998A (ko) 에스오메프라졸 유리염기 또는 그의 알칼리염을 포함하는 고미가 차폐된 약학 제제 및 이의 제조방법
AU2013347264B2 (en) Dispersible tablet
JP2006022060A (ja) 制酸・緩下用水分散液およびそのための錠剤
KR20150096787A (ko) Ｎ-[5-[2-(3,5-디메톡시페닐)에틸]-2ｈ-피라졸-3-일]-4-[(3ｒ,5ｓ)-3,5-디메틸피페라진-1-일]벤즈아미드의 약학 제제
JP2025527261A (ja) 新規製剤
US20150283083A1 (en) Dispersible Tablet
Nurdin et al. Development of Rapid Dispersible Tablet Preparations Using Synthetic and Natural Superdisintegrant Disintegrants: Comparative Performance Analysis
DK177906B1 (en) Dispersible tablet
JP2005320267A (ja) 小型のクラリスロマイシン高含有錠剤及びその製造方法
Upadhyay et al. Preparation and Evaluation of Fast Release Surface Solid Dispersion of Glibenclamide
HK1094152A1 (zh) 抗血栓形成的化合物的可在口中分散的药物组合物

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210219

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210225

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220208

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220316

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220527

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220614

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220713

R150 Certificate of patent or registration of utility model

Ref document number: 7111389

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350